179 related articles for article (PubMed ID: 38548788)
1. Altered perivascular spaces in subcortical white matter in Parkinson's disease patients with levodopa-induced dyskinesia.
Cao X; Gan C; Zhang H; Yuan Y; Sun H; Zhang L; Wang L; Zhang L; Zhang K
NPJ Parkinsons Dis; 2024 Mar; 10(1):71. PubMed ID: 38548788
[TBL] [Abstract][Full Text] [Related]
2. Microstructural and functional alterations of the ventral pallidum are associated with levodopa-induced dyskinesia in Parkinson's disease.
Gan Y; Su D; Zhang Z; Zhang Z; Yan R; Liu Z; Wang Z; Zhou J; Lam JST; Wu T; Jing J; Feng T
Eur J Neurol; 2024 Feb; 31(2):e16147. PubMed ID: 37975786
[TBL] [Abstract][Full Text] [Related]
3. Multimodal Imaging of Substantia Nigra in Parkinson's Disease with Levodopa-Induced Dyskinesia.
Su D; Gan Y; Zhang Z; Cui Y; Zhang Z; Liu Z; Wang Z; Zhou J; Sossi V; Stoessl AJ; Wu T; Jing J; Feng T
Mov Disord; 2023 Apr; 38(4):616-625. PubMed ID: 36799459
[TBL] [Abstract][Full Text] [Related]
4. Global and Regional Changes in Perivascular Space in Idiopathic and Familial Parkinson's Disease.
Donahue EK; Murdos A; Jakowec MW; Sheikh-Bahaei N; Toga AW; Petzinger GM; Sepehrband F
Mov Disord; 2021 May; 36(5):1126-1136. PubMed ID: 33470460
[TBL] [Abstract][Full Text] [Related]
5. Altered functional connectivity of cerebellar dentate nucleus in peak-dose dyskinesia in Parkinson's disease.
Zhang H; Wang L; Gan C; Cao X; Ji M; Sun H; Yuan Y; Zhang K
Front Aging Neurosci; 2022; 14():943179. PubMed ID: 36034152
[TBL] [Abstract][Full Text] [Related]
6.
Sun HM; Wang LN; Ji M; Gan CT; Yuan YS; Cao XY; Zhang H; Zhang KZ
Quant Imaging Med Surg; 2022 Jun; 12(6):3264-3275. PubMed ID: 35655818
[TBL] [Abstract][Full Text] [Related]
7. Cerebellar connectivity in Parkinson's disease with levodopa-induced dyskinesia.
Yoo HS; Choi YH; Chung SJ; Lee YH; Ye BS; Sohn YH; Lee JM; Lee PH
Ann Clin Transl Neurol; 2019 Nov; 6(11):2251-2260. PubMed ID: 31643140
[TBL] [Abstract][Full Text] [Related]
8. Contracted thalamic shape is associated with early development of levodopa-induced dyskinesia in Parkinson's disease.
Yoo HS; Lee EC; Chung SJ; Ye BS; Sohn YH; Seong JK; Lee PH
Sci Rep; 2022 Jul; 12(1):12631. PubMed ID: 35879381
[TBL] [Abstract][Full Text] [Related]
9. Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias.
Cerasa A; Salsone M; Morelli M; Pugliese P; Arabia G; Gioia CM; Novellino F; Quattrone A
Parkinsonism Relat Disord; 2013 Oct; 19(10):883-8. PubMed ID: 23769805
[TBL] [Abstract][Full Text] [Related]
10. White matter hyperintensities and risk of levodopa-induced dyskinesia in Parkinson's disease.
Chung SJ; Yoo HS; Lee YH; Jung JH; Baik K; Ye BS; Sohn YH; Lee PH
Ann Clin Transl Neurol; 2020 Feb; 7(2):229-238. PubMed ID: 32032471
[TBL] [Abstract][Full Text] [Related]
11. Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation.
Simoni S; Paoletti FP; Eusebi P; Cappelletti G; Filidei M; Brahimi E; Nigro P; Santangelo V; Parnetti L; Calabresi P; Tambasco N
J Parkinsons Dis; 2020; 10(3):927-934. PubMed ID: 32280105
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.
Andersen AD; Blaabjerg M; Binzer M; Kamal A; Thagesen H; Kjaer TW; Stenager E; Gramsbergen JBP
J Neurochem; 2017 May; 141(4):614-625. PubMed ID: 28244186
[TBL] [Abstract][Full Text] [Related]
13. The role of brain perivascular space burden in early-stage Parkinson's disease.
Shen T; Yue Y; Zhao S; Xie J; Chen Y; Tian J; Lv W; Lo CZ; Hsu YC; Kober T; Zhang B; Lai HY
NPJ Parkinsons Dis; 2021 Feb; 7(1):12. PubMed ID: 33547311
[TBL] [Abstract][Full Text] [Related]
14. Multimodal neuroimaging fusion unravel structural-functional-neurotransmitter change in Parkinson's disease with impulse control disorders.
Gan C; Cao X; Sun H; Ye S; Shi J; Shan A; Gao M; Wan C; Zhang K; Yuan Y
Neurobiol Dis; 2024 Aug; 198():106560. PubMed ID: 38852751
[TBL] [Abstract][Full Text] [Related]
15. Levodopa-induced dyskinesia is preceded by increased levels of anxiety and motor impairment in Parkinson's disease patients.
Dias CMV; Leal DAB; Brys I
Int J Neurosci; 2023 Dec; 133(12):1319-1325. PubMed ID: 35603453
[No Abstract] [Full Text] [Related]
16. Brain-Region Specific Metabolic Abnormalities in Parkinson's Disease and Levodopa-Induced Dyskinesia.
Yang C; Zhang T; Wang W; Xiang Y; Huang Q; Xie C; Zhao L; Zheng H; Yang Y; Gao H
Front Aging Neurosci; 2020; 12():75. PubMed ID: 32256342
[TBL] [Abstract][Full Text] [Related]
17. Altered brain structural topological properties in Parkinson's disease with levodopa-induced dyskinesias.
Wang L; Wang M; Si Q; Yuan Y; Ma K; Gan C; Zhang K
Parkinsonism Relat Disord; 2019 Oct; 67():36-41. PubMed ID: 31621605
[TBL] [Abstract][Full Text] [Related]
18. Magnetic Resonance Imaging-Visible Perivascular Spaces in Basal Ganglia Predict Cognitive Decline in Parkinson's Disease.
Park YW; Shin NY; Chung SJ; Kim J; Lim SM; Lee PH; Lee SK; Ahn KJ
Mov Disord; 2019 Nov; 34(11):1672-1679. PubMed ID: 31322758
[TBL] [Abstract][Full Text] [Related]
19. Levodopa-induced dyskinesias in Parkinson's disease increase cerebrospinal fluid nitric oxide metabolites' levels.
Santos-Lobato BL; Bortolanza M; Pinheiro LC; Batalhão ME; Pimentel ÂV; Capellari-Carnio E; Del-Bel EA; Tumas V
J Neural Transm (Vienna); 2022 Jan; 129(1):55-63. PubMed ID: 34940921
[TBL] [Abstract][Full Text] [Related]
20. Increased perivascular space volume in white matter and basal ganglia is associated with cognition in Parkinson's Disease.
Donahue EK; Foreman RP; Duran JJ; Jakowec MW; O'Neill J; Petkus AJ; Holschneider DP; Choupan J; Van Horn JD; Venkadesh S; Bayram E; Litvan I; Schiehser DM; Petzinger GM
Brain Imaging Behav; 2024 Feb; 18(1):57-65. PubMed ID: 37855955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
